New Zealand markets open in 1 hour 37 minutes

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4313-0.0187 (-4.16%)
As of 03:16PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 18.62M
Enterprise value -47.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.93
Price/book (mrq)0.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.23

Trading information

Stock price history

Beta (5Y monthly) 2.41
52-week change 3-73.37%
S&P500 52-week change 331.40%
52-week high 35.9500
52-week low 30.4110
50-day moving average 30.4585
200-day moving average 31.5051

Share statistics

Avg vol (3-month) 3422.94k
Avg vol (10-day) 3469.12k
Shares outstanding 541.3M
Implied shares outstanding 641.3M
Float 824.89M
% held by insiders 17.72%
% held by institutions 148.64%
Shares short (13 Sept 2024) 4248.99k
Short ratio (13 Sept 2024) 40.98
Short % of float (13 Sept 2024) 40.64%
Short % of shares outstanding (13 Sept 2024) 40.60%
Shares short (prior month 15 Aug 2024) 4205.43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-623.35%

Management effectiveness

Return on assets (ttm)-29.46%
Return on equity (ttm)-55.37%

Income statement

Revenue (ttm)9.57M
Revenue per share (ttm)0.23
Quarterly revenue growth (yoy)-25.60%
Gross profit (ttm)N/A
EBITDA -47.43M
Net income avi to common (ttm)-43.11M
Diluted EPS (ttm)-1.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)69.68M
Total cash per share (mrq)1.69
Total debt (mrq)3.69M
Total debt/equity (mrq)6.24%
Current ratio (mrq)5.17
Book value per share (mrq)1.43

Cash flow statement

Operating cash flow (ttm)-49.54M
Levered free cash flow (ttm)-33.4M